Clinical Trial MS200740-001 nicknamed SIMBA is well underway at the CCST site in Christchurch.  99 more volunteers will be dosed over the coming weeks.  This study is evaluating the equivalence of MSB11456 (Tocilizumab proposed biosimilar) with the Tocilizumab that is approved in both the USA and in the EU.  Principal Investigator is Dr Chris Wynne.